Puengan, Andrey G.

HRN: 13-58-04  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/29/2023
07/06/2023
TOPICAL
1%
OD
Burns
Waiting Final Action 
07/01/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/01/2023
07/08/2023
IV
1.5gram
Q 8hrs
Burns
Waiting Final Action 
07/03/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/03/2023
07/10/2023
IV
1%
Q12hrs
Superficial Thickness Burn
Waiting Final Action 
07/03/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/03/2023
07/10/2023
IV
1%
Q12hrs
Superficial Thickness Burn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: